CD4+ cell count criteria could control costs in US ADAPs

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1568, 2006-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CD4+ cell count criteria could control costs in US ADAPs

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 518, 2006-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Race and CD4⁺ T-cell count in HIV prognosis and treatment

By Achhra Amit C Amin Janaki

Future Virology, Vol. 7, Iss. 2, 2012-02 ,pp. : 193-203

Future Medicine

Access to resources Recommend Favorite

Micronutrient supplementation significantly increases CD4+ cell count in patients with HIV-1 infections

Inpharma, Vol. 1, Iss. 1554, 2006-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Analysis of Severe Hepatic Events Associated with Nevirapine-Containing Regimens: CD4+ T-Cell Count and Gender in Hepatitis C Seropositive and Seronegative Patients

By Torti Carlo

Drug Safety, Vol. 30, Iss. 12, 2007-01 ,pp. : 1161-1169

Adis International

Access to resources Recommend Favorite

EU to grant $US1b to global fund, pharma firms donate to US ADAPs

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 423, 2003-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite